A retrospective study aseessing the efficacy of Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat fixed dose combination in virologically suppressed HIV-1 infected adults with or without the archived NRTI resistance mutation M184V/I
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 30 Dec 2016 New trial record